Treatment of Chiclero's ulcer with miltefosine;Chiclero ulcera behandeld met miltefosine

Nederlands Tijdschrift voor Dermatologie en Venereologie

Volumn 17, Issue 7, 2007, Pages 246-251

  Van Der Snoek, E M ^a   Lammers, A M ^a   Kortbeek, L M ^b   Jaspers, C A J J ^a  

^a CENTRAL MILITARY HOSPITAL   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cutaneous leishmaniasis; Ear shell; Hexadecylphosphocholine (miltefosine); New World; Tropical ulcers

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MILTEFOSINE; PAROMOMYCIN; PENTAMIDINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CENTRAL AMERICA; HUMAN; MALE; PUNCH BIOPSY; SKIN LEISHMANIASIS; UNSPECIFIED SIDE EFFECT;

EID: 35548975088     PISSN: 09258604     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Van der Snoek EM, De Waard-van der Spek FB, Den Hollander JC, Munte K, Sluiters JF. Leishmaniasis: een vervelende vakantieherinnering. Ned Tijdschr Derm Venereol 2005;15:270-6.
2. Zeegelaar JK, Faber WR. Tien jaar cutane leishmaniasis in het AMC. Ned Tijdschr Derm Venereol 2004;14:206-7.
3. Zeegelaar JE, Steketee WH, van Thiel PP, Wetsteyn JC, Kager PA, Faber WR. Changing pattern of imported cutaneous leishmaniasis in the Netherlands. Clin Exp Dermatol 2005;30:1-5.
4. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
5. Berman J. Current treatment approaches to Leishmaniasis. Curr Opin Infect Dis 2003;16:397-401.
6. Sindermann H, Croft SL, Engel KR, et al. Miltefosine (Impavido): the first oral treatment against Leishmaniasis. Med Microbiol Immunol 2004;193:173-80.
7. Sluiters JF. Leishmaniasis. In Diagnostisch Kompas 2003. Amstelveen: College voor Zorgverzekeringen, 2003.
8. Guerin Ph J, Olliaro P, Sundar S, et al. Visceral Leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002;2:494-501.
9. Van der Snoek EM, De Waard-van der Spek FB, Den Hollander JC, Munte K, Sluiters JF. Leishmaniasis: opnieuw, met een leidraad voor de therapie. Ned Tijdschr Derm Venereol 2006;16:182-4.
10. Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006;6:342-9.
11. Marfan J, Niederwieser I, Makia ND, Beck HP, Felger I. Diagnostic genotyping of Old and New World Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 2003;46:115-24.
12. Hepburn NC, Tidman MJ, Hunter JAA. Cutaneous leishmaniasis in British troops from Belize. Br J Dermatol 1993;128:63-8.
13. Palmer RA, Tran D, Hepburn NC, Ashton RE. The management of cutaneous leishmaniasis from Belize. Clin Exp Dermatol 2001;26:16-20.
14. Antonovich DD, Callen JP. No walk in the park. Am J Med 2005;118:715-6.
15. Sanchez JL, Diniega BM, Small JW, et al. Epidemiologic investigation of an outbreak of cutaneous leishmaniasis in a defined geographic focus of transmission. Am J Trop Med Hyg 1992;47:47-54.
16. Lawn SD, Whetham J, Chiodini PL, et al. New world mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers. QJM 2004;97:781-8.
17. Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004;53:158-66.
18. Arana B, Rizzo N, Diaz A. Chemotherapy of cutaneous leishmaniasis: a review. Med Microbiol Immunol 2001;190:93-5.
19. Moskowitz PF, Kurban AK. Treatment of cutaneous leishmaniasis: retrospectives and advances for the 21st century. Clin Dermatol 1999;17:305-15.
20. Berman JD. Treatment of New World cutaneous and mucosal leishmaniases. Clin Dermatol 1996;14:519-22.
21. Navin TR, Arana BA, Arana FE, Berman JD, Chajon JF. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis 1992;165:528-34.
22. Calvopina M, Guevara AG, Armijos RX, Hashiguchi Y, Davidson RN, Cooper PJ. Itraconazole in the treatment of New World mucocutaneous leishmaniasis. Int J Dermatol 2004;43:659-63.
23. Saenz RE, Paz H, Berman JD. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Am J Med 1990;89:147-55.
24. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 2004;10:307-15.
25. Dorlo TP, Eggelte TA, Beijnen JH, de Vries PJ. Miltefosine: een nieuw geneesmiddel voor leishmaniasis. Ned Tijdschr Geneeskd 2006;150:2697-701.
26. Soto J, Toledo J, Gutierrez P, et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001;33:E57-61.
27. Brown M, Noursadeghi M, Boyle J, Davidson RN. Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis. Br J Dermatol 2005;153:203-5.
28. Khatami A, Firooz A, Gorouhi F, Dowlati Y. Treatment of acute Old World cutaneous leishmaniasis: A systematic review of the randomized controlled trials. J Am Acad Dermatol 2007 Mar 2;335:e1-c29.
29. Soto J, Arana BA, Toledo J, et al. Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis 2004;38:1266-72.
30. Soto J, Berman J. Treatment of New World cutaneous leishmaniasis with miltefosine. Trans R Soc Trop Med Hvg 2006;100:S34-40.
31. Soto J, Toledo J, Valda L, et al. Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis 2007;44:350-6.
32. Escobar P, Matu S, Marques C, Croft SL. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta Trop 2002;81:151-7.